Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cortical Excitability and Atomoxetine in ADHD
NCT01330693Phase 3Unknown
- Sponsor
- University of Cincinnati
- Start
- Sep 2009
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Cincinnati. Status: unknown.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01330693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01330693.